Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Dasotraline Pediatric Extension Study

ClinicalTrials.gov ID: NCT02457819

Public ClinicalTrials.gov record NCT02457819. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 2:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open label 26 week extension study for subjects who completed SEP360-202.

Study identification

NCT ID
NCT02457819
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
237 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2015
Primary completion
Feb 1, 2017
Completion
Feb 1, 2017
Last update posted
Jan 27, 2020

2015 – 2017

United States locations

U.S. sites
36
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
Harmonex Neuroscience Research, Inc Dothan Alabama 36303
ProScience Research Group Culver City California 90230
Elite Clinical Trials, Inc. Wildomar California 92595
MCB Clinical Research Centers, LLC Colorado Springs Colorado 80910
Sarkis Clinical Trials Gainesville Florida 32607
Indago Research Health Center, Inc. Hialeah Florida 33012
Clinical Neuroscience Solutions, Inc Jacksonville Florida 32256
Florida Clinical Research Center, LLC Maitland Florida 32751
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801
Miami Research Associates, LLC South Miami Florida 33143
Atlanta Center for Medical Research Atlanta Georgia 30331
iResearch Atlanta, LLC Decatur Georgia 30030
Capstone Clinical Research Libertyville Illinois 60418
Baber Research Group, Inc. Naperville Illinois 630-896-3530
Goldpoint Clinical Research, LLC. Indianapolis Indiana 46260
Pedia Research,LLC Newburgh Indiana 47630
Psychiatric Associates Overland Park Kansas 66211
Pedia Research,LLC Owensboro Kentucky 42301
Neurobehavioral Medicine Group, Clinical Trials Division Bloomfield Hills Michigan 48302
Clinical Trials group at the Rochester Center for Behavioral Medicine Rochester Hills Michigan 48307
St. Charles Psychiatric Associates - Midwest Research Group Saint Charles Missouri 63304
Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas Nevada 89128
Pharmaceutical Research Associates, Inc. Marlton New Jersey 08053
Richarmond Behavioral Associates Staten Island New York 10312
University of Cincinnati/Department of Psychiatry and Behavioral Neuroscience Cincinnati Ohio 45219
University Hospitals Case Medical Center Cleveland Ohio 44106
IPS Research Company Oklahoma City Oklahoma 73103
Cutting Edge Research Group Oklahoma City Oklahoma 73116
Cyn3rgy Research Gresham Oregon 97030
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464
BioBehavioral Research of Austin P.C. Austin Texas 78759
Bayou City Research, Ltd. Houston Texas 77007
Houston Clinical Trials, LLC Houston Texas 77098
Clinical Trials of Texas, Inc. San Antonio Texas 78229
Road Runner Research, Ltd. San Antonio Texas 78258
Family Psychiatry of the Woodlands The Woodlands Texas 77381

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02457819, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2020 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02457819 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →